Bülent Salman

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Elizabeth M. Jaffee · 2 shared papers, 2013–2016 · strength 0.10
   • Paper Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methyla… DOI 10.1158/0008-5472.can-15-3264↗
   • Paper Vaccine therapy for pancreatic cancer. DOI 10.4161/onci.26662↗
2. Lei Zheng · 2 shared papers, 2013–2016 · strength 0.10
   • Paper Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methyla… DOI 10.1158/0008-5472.can-15-3264↗
   • Paper Vaccine therapy for pancreatic cancer. DOI 10.4161/onci.26662↗
3. Jin Peng He · 1 shared paper, 2016 · strength 0.05
   • Paper Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent developmen… DOI 10.1016/j.hpb.2015.10.010↗
4. Neda Rezaee · 1 shared paper, 2016 · strength 0.05
   • Paper Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent developmen… DOI 10.1016/j.hpb.2015.10.010↗
5. Joseph M. Herman · 1 shared paper, 2016 · strength 0.05
   • Paper Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent developmen… DOI 10.1016/j.hpb.2015.10.010↗
6. Laura DeLong Wood · 1 shared paper, 2016 · strength 0.05
   • Paper Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent developmen… DOI 10.1016/j.hpb.2015.10.010↗
7. Christopher Lee Wolfgang · 1 shared paper, 2016 · strength 0.05
   • Paper Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent developmen… DOI 10.1016/j.hpb.2015.10.010↗
8. Matthew John Weiss · 1 shared paper, 2016 · strength 0.05
   • Paper Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent developmen… DOI 10.1016/j.hpb.2015.10.010↗
9. Nita Ahuja · 1 shared paper, 2016 · strength 0.05
   • Paper Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent developmen… DOI 10.1016/j.hpb.2015.10.010↗
10. Anne Marie Lennon · 1 shared paper, 2016 · strength 0.05
    • Paper Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent developmen… DOI 10.1016/j.hpb.2015.10.010↗
11. Ralph H. Hruban · 1 shared paper, 2016 · strength 0.05
    • Paper Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent developmen… DOI 10.1016/j.hpb.2015.10.010↗
12. Robert A. Anders · 1 shared paper, 2016 · strength 0.05
    • Paper Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methyla… DOI 10.1158/0008-5472.can-15-3264↗
13. Agnieszka A. Rucki · 1 shared paper, 2016 · strength 0.05
    • Paper Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methyla… DOI 10.1158/0008-5472.can-15-3264↗
14. Kenji Fujiwara · 1 shared paper, 2016 · strength 0.05
    • Paper Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methyla… DOI 10.1158/0008-5472.can-15-3264↗
15. Qian Xiao · 1 shared paper, 2016 · strength 0.05
    • Paper Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methyla… DOI 10.1158/0008-5472.can-15-3264↗
16. Adrian Gerard Murphy · 1 shared paper, 2016 · strength 0.05
    • Paper Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methyla… DOI 10.1158/0008-5472.can-15-3264↗
17. Christopher L. Wolfgang · 1 shared paper, 2016 · strength 0.05
    • Paper Cancer-Associated Fibroblasts in Pancreatic Cancer Are Reprogrammed by Tumor-Induced Alterations in Genomic DNA Methyla… DOI 10.1158/0008-5472.can-15-3264↗
18. Barish H. Edil · 1 shared paper, 2013 · strength 0.05
    • Paper Vaccine therapy for pancreatic cancer. DOI 10.4161/onci.26662↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.